. 2003 Oct 23;349(17):1676-9; discussion 1676-9.
doi: 10.1056/NEJM200310233491721.
Renal failure with the use of zoledronic acid
- PMID: 14573746
- DOI: 10.1056/NEJM200310233491721
Item in Clipboard
Renal failure with the use of zoledronic acid
N Engl J Med.
.
No abstract available
Similar articles
-
Zoledronic Acid and renal toxicity: data from French adverse effect reporting database.Ann Pharmacother. 2005 Jul-Aug;39(7-8):1194-7. doi: 10.1345/aph.1E589. Epub 2005 Jun 14. Ann Pharmacother. 2005. PMID: 15956222
-
[Acute kidney failure caused by zoledronic acid (Zometa)].Nefrologia. 2006;26(4):502-3. Nefrologia. 2006. PMID: 17058868 Spanish. No abstract available.
-
Impact of zoledronic acid on renal function in patients with cancer: Clinical significance and development of a predictive model.J Support Oncol. 2006 Nov-Dec;4(10):524-9. J Support Oncol. 2006. PMID: 17136870
-
Osteonecrosis of jaw in patient with hormone-refractory prostate cancer treated with zoledronic acid.Urology. 2005 Sep;66(3):658. doi: 10.1016/j.urology.2005.03.028. Urology. 2005. PMID: 16140106 Review.
-
Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases.Oral Oncol. 2006 Mar;42(3):327-9. doi: 10.1016/j.oraloncology.2005.08.001. Epub 2005 Nov 4. Oral Oncol. 2006. PMID: 16275156 Review. No abstract available.
Cited by
-
Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists.J Bone Miner Res. 2013 Jan;28(1):92-107. doi: 10.1002/jbmr.1732. J Bone Miner Res. 2013. PMID: 22903605 Free PMC article.
-
Treatment of Diabetes and Osteoporosis-A Reciprocal Risk?Biomedicines. 2022 Sep 5;10(9):2191. doi: 10.3390/biomedicines10092191. Biomedicines. 2022. PMID: 36140292 Free PMC article. Review.
-
Management of cancer treatment-induced bone loss in early breast and prostate cancer -- a consensus paper of the Belgian Bone Club.Osteoporos Int. 2007 Nov;18(11):1439-50. doi: 10.1007/s00198-007-0439-4. Epub 2007 Aug 10. Osteoporos Int. 2007. PMID: 17690930 Review.
-
Renal safety of zoledronic acid for osteoporosis in adults 75 years and older.Osteoporos Int. 2022 Nov;33(11):2417-2422. doi: 10.1007/s00198-022-06499-4. Epub 2022 Jul 13. Osteoporos Int. 2022. PMID: 35829757
-
Thrombotic thrombocytopenic purpura following zoledronic acid infusion with a fatal outcome.BMJ Case Rep. 2009;2009:bcr09.2008.0923. doi: 10.1136/bcr.09.2008.0923. Epub 2009 Mar 31. BMJ Case Rep. 2009. PMID: 21686558 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
